nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—type 2 diabetes mellitus	0.291	1	CbGaD
Paricalcitol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0462	0.152	CbGbCtD
Paricalcitol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0411	0.136	CbGbCtD
Paricalcitol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0376	0.124	CbGbCtD
Paricalcitol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0329	0.109	CbGbCtD
Paricalcitol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0297	0.0982	CbGbCtD
Paricalcitol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0225	0.0744	CbGbCtD
Paricalcitol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0216	0.0713	CbGbCtD
Paricalcitol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0216	0.0713	CbGbCtD
Paricalcitol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0204	0.0675	CbGbCtD
Paricalcitol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0152	0.0503	CbGbCtD
Paricalcitol—CYP3A4—Losartan—type 2 diabetes mellitus	0.0139	0.046	CbGbCtD
Paricalcitol—VDR—leg—type 2 diabetes mellitus	0.00862	0.22	CbGeAlD
Paricalcitol—VDR—hindlimb—type 2 diabetes mellitus	0.0077	0.197	CbGeAlD
Paricalcitol—CYP24A1—nephron tubule—type 2 diabetes mellitus	0.00332	0.0848	CbGeAlD
Paricalcitol—CYP24A1—kidney—type 2 diabetes mellitus	0.00291	0.0745	CbGeAlD
Paricalcitol—UGT1A4—kidney—type 2 diabetes mellitus	0.00291	0.0745	CbGeAlD
Paricalcitol—CYP24A1—cortex of kidney—type 2 diabetes mellitus	0.00284	0.0726	CbGeAlD
Paricalcitol—UGT1A4—liver—type 2 diabetes mellitus	0.00184	0.0471	CbGeAlD
Paricalcitol—VDR—nephron tubule—type 2 diabetes mellitus	0.00183	0.0467	CbGeAlD
Paricalcitol—VDR—cardiovascular system—type 2 diabetes mellitus	0.00164	0.0419	CbGeAlD
Paricalcitol—VDR—kidney—type 2 diabetes mellitus	0.00161	0.041	CbGeAlD
Paricalcitol—VDR—cortex of kidney—type 2 diabetes mellitus	0.00156	0.04	CbGeAlD
Paricalcitol—VDR—adipose tissue—type 2 diabetes mellitus	0.00145	0.037	CbGeAlD
Paricalcitol—Cholecalciferol—CYP11A1—type 2 diabetes mellitus	0.00114	0.36	CrCbGaD
Paricalcitol—Ergocalciferol—AR—type 2 diabetes mellitus	0.000927	0.293	CrCbGaD
Paricalcitol—CYP3A4—kidney—type 2 diabetes mellitus	0.000537	0.0137	CbGeAlD
Paricalcitol—Calcitriol—CYP3A4—type 2 diabetes mellitus	0.000456	0.144	CrCbGaD
Paricalcitol—Ergocalciferol—CYP3A4—type 2 diabetes mellitus	0.000364	0.115	CrCbGaD
Paricalcitol—CYP3A4—liver—type 2 diabetes mellitus	0.000339	0.00867	CbGeAlD
Paricalcitol—Cholecalciferol—CYP3A4—type 2 diabetes mellitus	0.000276	0.0874	CrCbGaD
Paricalcitol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000129	0.000517	CcSEcCtD
Paricalcitol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000129	0.000516	CcSEcCtD
Paricalcitol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000129	0.000515	CcSEcCtD
Paricalcitol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000129	0.000515	CcSEcCtD
Paricalcitol—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000515	CcSEcCtD
Paricalcitol—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000515	CcSEcCtD
Paricalcitol—Shock—Metformin—type 2 diabetes mellitus	0.000129	0.000514	CcSEcCtD
Paricalcitol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000128	0.000513	CcSEcCtD
Paricalcitol—Malaise—Losartan—type 2 diabetes mellitus	0.000128	0.000513	CcSEcCtD
Paricalcitol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000128	0.000513	CcSEcCtD
Paricalcitol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000128	0.000513	CcSEcCtD
Paricalcitol—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000128	0.000513	CcSEcCtD
Paricalcitol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000128	0.000512	CcSEcCtD
Paricalcitol—Vertigo—Losartan—type 2 diabetes mellitus	0.000128	0.000511	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000128	0.000511	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000128	0.000511	CcSEcCtD
Paricalcitol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000128	0.00051	CcSEcCtD
Paricalcitol—Syncope—Losartan—type 2 diabetes mellitus	0.000127	0.00051	CcSEcCtD
Paricalcitol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000127	0.000509	CcSEcCtD
Paricalcitol—Leukopenia—Losartan—type 2 diabetes mellitus	0.000127	0.000509	CcSEcCtD
Paricalcitol—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000127	0.000509	CcSEcCtD
Paricalcitol—Skin disorder—Metformin—type 2 diabetes mellitus	0.000127	0.000508	CcSEcCtD
Paricalcitol—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000126	0.000506	CcSEcCtD
Paricalcitol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000126	0.000505	CcSEcCtD
Paricalcitol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000126	0.000505	CcSEcCtD
Paricalcitol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000126	0.000505	CcSEcCtD
Paricalcitol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000126	0.000503	CcSEcCtD
Paricalcitol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000126	0.000503	CcSEcCtD
Paricalcitol—Palpitations—Losartan—type 2 diabetes mellitus	0.000126	0.000503	CcSEcCtD
Paricalcitol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000125	0.000501	CcSEcCtD
Paricalcitol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000125	0.000501	CcSEcCtD
Paricalcitol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000125	0.0005	CcSEcCtD
Paricalcitol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000125	0.0005	CcSEcCtD
Paricalcitol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000125	0.000499	CcSEcCtD
Paricalcitol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000125	0.000499	CcSEcCtD
Paricalcitol—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000125	0.000499	CcSEcCtD
Paricalcitol—Anorexia—Metformin—type 2 diabetes mellitus	0.000125	0.000498	CcSEcCtD
Paricalcitol—Cough—Losartan—type 2 diabetes mellitus	0.000124	0.000496	CcSEcCtD
Paricalcitol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000124	0.000496	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000124	0.000496	CcSEcCtD
Paricalcitol—Alopecia—Ramipril—type 2 diabetes mellitus	0.000124	0.000495	CcSEcCtD
Paricalcitol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000124	0.000495	CcSEcCtD
Paricalcitol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000123	0.000494	CcSEcCtD
Paricalcitol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000123	0.000494	CcSEcCtD
Paricalcitol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000123	0.000493	CcSEcCtD
Paricalcitol—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000123	0.000493	CcSEcCtD
Paricalcitol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000123	0.000492	CcSEcCtD
Paricalcitol—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000123	0.000491	CcSEcCtD
Paricalcitol—Constipation—Valsartan—type 2 diabetes mellitus	0.000123	0.000491	CcSEcCtD
Paricalcitol—Infection—Irbesartan—type 2 diabetes mellitus	0.000122	0.00049	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000122	0.00049	CcSEcCtD
Paricalcitol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000122	0.000489	CcSEcCtD
Paricalcitol—Hypotension—Metformin—type 2 diabetes mellitus	0.000122	0.000489	CcSEcCtD
Paricalcitol—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000122	0.000488	CcSEcCtD
Paricalcitol—Shock—Irbesartan—type 2 diabetes mellitus	0.000121	0.000485	CcSEcCtD
Paricalcitol—Pain—Orlistat—type 2 diabetes mellitus	0.000121	0.000485	CcSEcCtD
Paricalcitol—Chest pain—Losartan—type 2 diabetes mellitus	0.000121	0.000484	CcSEcCtD
Paricalcitol—Arthralgia—Losartan—type 2 diabetes mellitus	0.000121	0.000484	CcSEcCtD
Paricalcitol—Myalgia—Losartan—type 2 diabetes mellitus	0.000121	0.000484	CcSEcCtD
Paricalcitol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000484	CcSEcCtD
Paricalcitol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000121	0.000484	CcSEcCtD
Paricalcitol—Anxiety—Losartan—type 2 diabetes mellitus	0.000121	0.000483	CcSEcCtD
Paricalcitol—Rash—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00048	CcSEcCtD
Paricalcitol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00048	CcSEcCtD
Paricalcitol—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00012	0.000479	CcSEcCtD
Paricalcitol—Tension—Ramipril—type 2 diabetes mellitus	0.00012	0.000479	CcSEcCtD
Paricalcitol—Discomfort—Losartan—type 2 diabetes mellitus	0.00012	0.000479	CcSEcCtD
Paricalcitol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000119	0.000478	CcSEcCtD
Paricalcitol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000119	0.000477	CcSEcCtD
Paricalcitol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000477	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000119	0.000476	CcSEcCtD
Paricalcitol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000119	0.000476	CcSEcCtD
Paricalcitol—Nervousness—Ramipril—type 2 diabetes mellitus	0.000118	0.000474	CcSEcCtD
Paricalcitol—Dry mouth—Losartan—type 2 diabetes mellitus	0.000118	0.000474	CcSEcCtD
Paricalcitol—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000118	0.00047	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000117	0.000469	CcSEcCtD
Paricalcitol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000117	0.000469	CcSEcCtD
Paricalcitol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000117	0.000469	CcSEcCtD
Paricalcitol—Confusional state—Losartan—type 2 diabetes mellitus	0.000117	0.000468	CcSEcCtD
Paricalcitol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000117	0.000468	CcSEcCtD
Paricalcitol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000116	0.000466	CcSEcCtD
Paricalcitol—Somnolence—Metformin—type 2 diabetes mellitus	0.000116	0.000465	CcSEcCtD
Paricalcitol—Oedema—Losartan—type 2 diabetes mellitus	0.000116	0.000464	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000116	0.000464	CcSEcCtD
Paricalcitol—Infection—Losartan—type 2 diabetes mellitus	0.000115	0.000461	CcSEcCtD
Paricalcitol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000115	0.000461	CcSEcCtD
Paricalcitol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000115	0.00046	CcSEcCtD
Paricalcitol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000115	0.00046	CcSEcCtD
Paricalcitol—Shock—Losartan—type 2 diabetes mellitus	0.000114	0.000457	CcSEcCtD
Paricalcitol—Urticaria—Valsartan—type 2 diabetes mellitus	0.000114	0.000456	CcSEcCtD
Paricalcitol—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000114	0.000455	CcSEcCtD
Paricalcitol—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000114	0.000455	CcSEcCtD
Paricalcitol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000113	0.000454	CcSEcCtD
Paricalcitol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000453	CcSEcCtD
Paricalcitol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.000452	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000113	0.000451	CcSEcCtD
Paricalcitol—Fatigue—Metformin—type 2 diabetes mellitus	0.000113	0.000451	CcSEcCtD
Paricalcitol—Urticaria—Orlistat—type 2 diabetes mellitus	0.000113	0.000451	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000112	0.00045	CcSEcCtD
Paricalcitol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000112	0.000449	CcSEcCtD
Paricalcitol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000112	0.000448	CcSEcCtD
Paricalcitol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000112	0.000448	CcSEcCtD
Paricalcitol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000112	0.000448	CcSEcCtD
Paricalcitol—Agitation—Ramipril—type 2 diabetes mellitus	0.000112	0.000448	CcSEcCtD
Paricalcitol—Constipation—Metformin—type 2 diabetes mellitus	0.000112	0.000447	CcSEcCtD
Paricalcitol—Angioedema—Ramipril—type 2 diabetes mellitus	0.000111	0.000446	CcSEcCtD
Paricalcitol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000443	CcSEcCtD
Paricalcitol—Anorexia—Losartan—type 2 diabetes mellitus	0.000111	0.000443	CcSEcCtD
Paricalcitol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000111	0.000442	CcSEcCtD
Paricalcitol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00011	0.000442	CcSEcCtD
Paricalcitol—Malaise—Ramipril—type 2 diabetes mellitus	0.00011	0.00044	CcSEcCtD
Paricalcitol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00011	0.00044	CcSEcCtD
Paricalcitol—Rash—Glyburide—type 2 diabetes mellitus	0.00011	0.000439	CcSEcCtD
Paricalcitol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00011	0.000439	CcSEcCtD
Paricalcitol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00011	0.000438	CcSEcCtD
Paricalcitol—Vertigo—Ramipril—type 2 diabetes mellitus	0.00011	0.000438	CcSEcCtD
Paricalcitol—Syncope—Ramipril—type 2 diabetes mellitus	0.000109	0.000438	CcSEcCtD
Paricalcitol—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000109	0.000437	CcSEcCtD
Paricalcitol—Headache—Glyburide—type 2 diabetes mellitus	0.000109	0.000436	CcSEcCtD
Paricalcitol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000109	0.000434	CcSEcCtD
Paricalcitol—Hypotension—Losartan—type 2 diabetes mellitus	0.000108	0.000434	CcSEcCtD
Paricalcitol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000108	0.000431	CcSEcCtD
Paricalcitol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000108	0.000431	CcSEcCtD
Paricalcitol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000107	0.000429	CcSEcCtD
Paricalcitol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000107	0.000429	CcSEcCtD
Paricalcitol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000107	0.000428	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000107	0.000428	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000106	0.000426	CcSEcCtD
Paricalcitol—Cough—Ramipril—type 2 diabetes mellitus	0.000106	0.000426	CcSEcCtD
Paricalcitol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000106	0.000425	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000106	0.000423	CcSEcCtD
Paricalcitol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000106	0.000423	CcSEcCtD
Paricalcitol—Pain—Irbesartan—type 2 diabetes mellitus	0.000105	0.000422	CcSEcCtD
Paricalcitol—Constipation—Irbesartan—type 2 diabetes mellitus	0.000105	0.000422	CcSEcCtD
Paricalcitol—Insomnia—Losartan—type 2 diabetes mellitus	0.000105	0.00042	CcSEcCtD
Paricalcitol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000104	0.000418	CcSEcCtD
Paricalcitol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000104	0.000417	CcSEcCtD
Paricalcitol—Urticaria—Metformin—type 2 diabetes mellitus	0.000104	0.000415	CcSEcCtD
Paricalcitol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000104	0.000415	CcSEcCtD
Paricalcitol—Myalgia—Ramipril—type 2 diabetes mellitus	0.000104	0.000415	CcSEcCtD
Paricalcitol—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000104	0.000415	CcSEcCtD
Paricalcitol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000103	0.000414	CcSEcCtD
Paricalcitol—Anxiety—Ramipril—type 2 diabetes mellitus	0.000103	0.000414	CcSEcCtD
Paricalcitol—Nausea—Glyburide—type 2 diabetes mellitus	0.000103	0.000413	CcSEcCtD
Paricalcitol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000103	0.000413	CcSEcCtD
Paricalcitol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000103	0.000413	CcSEcCtD
Paricalcitol—Somnolence—Losartan—type 2 diabetes mellitus	0.000103	0.000413	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000103	0.000412	CcSEcCtD
Paricalcitol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000103	0.000412	CcSEcCtD
Paricalcitol—Discomfort—Ramipril—type 2 diabetes mellitus	0.000103	0.00041	CcSEcCtD
Paricalcitol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000102	0.000409	CcSEcCtD
Paricalcitol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000102	0.000407	CcSEcCtD
Paricalcitol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000102	0.000407	CcSEcCtD
Paricalcitol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000101	0.000406	CcSEcCtD
Paricalcitol—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000101	0.000406	CcSEcCtD
Paricalcitol—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000101	0.000404	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000403	CcSEcCtD
Paricalcitol—Confusional state—Ramipril—type 2 diabetes mellitus	0.0001	0.000401	CcSEcCtD
Paricalcitol—Pruritus—Orlistat—type 2 diabetes mellitus	0.0001	0.000401	CcSEcCtD
Paricalcitol—Fatigue—Losartan—type 2 diabetes mellitus	0.0001	0.0004	CcSEcCtD
Paricalcitol—Oedema—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000398	CcSEcCtD
Paricalcitol—Vomiting—Gliclazide—type 2 diabetes mellitus	9.93e-05	0.000397	CcSEcCtD
Paricalcitol—Pain—Losartan—type 2 diabetes mellitus	9.92e-05	0.000397	CcSEcCtD
Paricalcitol—Constipation—Losartan—type 2 diabetes mellitus	9.92e-05	0.000397	CcSEcCtD
Paricalcitol—Rash—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000394	CcSEcCtD
Paricalcitol—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.83e-05	0.000394	CcSEcCtD
Paricalcitol—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000393	CcSEcCtD
Paricalcitol—Urticaria—Irbesartan—type 2 diabetes mellitus	9.79e-05	0.000392	CcSEcCtD
Paricalcitol—Shock—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000392	CcSEcCtD
Paricalcitol—Headache—Gliclazide—type 2 diabetes mellitus	9.78e-05	0.000391	CcSEcCtD
Paricalcitol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.76e-05	0.00039	CcSEcCtD
Paricalcitol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.00039	CcSEcCtD
Paricalcitol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.00039	CcSEcCtD
Paricalcitol—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.7e-05	0.000388	CcSEcCtD
Paricalcitol—Skin disorder—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000387	CcSEcCtD
Paricalcitol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000385	CcSEcCtD
Paricalcitol—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.56e-05	0.000383	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.49e-05	0.00038	CcSEcCtD
Paricalcitol—Dizziness—Valsartan—type 2 diabetes mellitus	9.49e-05	0.00038	CcSEcCtD
Paricalcitol—Anorexia—Ramipril—type 2 diabetes mellitus	9.48e-05	0.00038	CcSEcCtD
Paricalcitol—Dizziness—Orlistat—type 2 diabetes mellitus	9.37e-05	0.000375	CcSEcCtD
Paricalcitol—Asthenia—Metformin—type 2 diabetes mellitus	9.37e-05	0.000375	CcSEcCtD
Paricalcitol—Hypotension—Ramipril—type 2 diabetes mellitus	9.3e-05	0.000372	CcSEcCtD
Paricalcitol—Nausea—Gliclazide—type 2 diabetes mellitus	9.27e-05	0.000371	CcSEcCtD
Paricalcitol—Pruritus—Metformin—type 2 diabetes mellitus	9.24e-05	0.00037	CcSEcCtD
Paricalcitol—Urticaria—Losartan—type 2 diabetes mellitus	9.22e-05	0.000369	CcSEcCtD
Paricalcitol—Body temperature increased—Losartan—type 2 diabetes mellitus	9.17e-05	0.000367	CcSEcCtD
Paricalcitol—Abdominal pain—Losartan—type 2 diabetes mellitus	9.17e-05	0.000367	CcSEcCtD
Paricalcitol—Vomiting—Valsartan—type 2 diabetes mellitus	9.12e-05	0.000365	CcSEcCtD
Paricalcitol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.08e-05	0.000364	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000363	CcSEcCtD
Paricalcitol—Rash—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000362	CcSEcCtD
Paricalcitol—Dermatitis—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000362	CcSEcCtD
Paricalcitol—Vomiting—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000361	CcSEcCtD
Paricalcitol—Insomnia—Ramipril—type 2 diabetes mellitus	9e-05	0.00036	CcSEcCtD
Paricalcitol—Headache—Valsartan—type 2 diabetes mellitus	8.99e-05	0.00036	CcSEcCtD
Paricalcitol—Diarrhoea—Metformin—type 2 diabetes mellitus	8.94e-05	0.000358	CcSEcCtD
Paricalcitol—Rash—Orlistat—type 2 diabetes mellitus	8.94e-05	0.000358	CcSEcCtD
Paricalcitol—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000358	CcSEcCtD
Paricalcitol—Dermatitis—Orlistat—type 2 diabetes mellitus	8.93e-05	0.000357	CcSEcCtD
Paricalcitol—Headache—Orlistat—type 2 diabetes mellitus	8.88e-05	0.000355	CcSEcCtD
Paricalcitol—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000355	CcSEcCtD
Paricalcitol—Asthenia—Irbesartan—type 2 diabetes mellitus	8.84e-05	0.000354	CcSEcCtD
Paricalcitol—Somnolence—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000354	CcSEcCtD
Paricalcitol—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.76e-05	0.00035	CcSEcCtD
Paricalcitol—Pruritus—Irbesartan—type 2 diabetes mellitus	8.72e-05	0.000349	CcSEcCtD
Paricalcitol—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000346	CcSEcCtD
Paricalcitol—Dizziness—Metformin—type 2 diabetes mellitus	8.64e-05	0.000346	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	8.6e-05	0.000756	CbGpPWpGaD
Paricalcitol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000344	CcSEcCtD
Paricalcitol—Fatigue—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000343	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	8.56e-05	0.000753	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.56e-05	0.000752	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYTB—type 2 diabetes mellitus	8.56e-05	0.000752	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.55e-05	0.000342	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	8.55e-05	0.000752	CbGpPWpGaD
Paricalcitol—Nausea—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000341	CcSEcCtD
Paricalcitol—Constipation—Ramipril—type 2 diabetes mellitus	8.51e-05	0.00034	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	8.51e-05	0.000748	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	8.45e-05	0.000743	CbGpPWpGaD
Paricalcitol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000338	CcSEcCtD
Paricalcitol—Nausea—Orlistat—type 2 diabetes mellitus	8.42e-05	0.000337	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PCK1—type 2 diabetes mellitus	8.34e-05	0.000733	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.34e-05	0.000733	CbGpPWpGaD
Paricalcitol—Asthenia—Losartan—type 2 diabetes mellitus	8.32e-05	0.000333	CcSEcCtD
Paricalcitol—Vomiting—Metformin—type 2 diabetes mellitus	8.31e-05	0.000332	CcSEcCtD
Paricalcitol—Rash—Metformin—type 2 diabetes mellitus	8.24e-05	0.00033	CcSEcCtD
Paricalcitol—Dermatitis—Metformin—type 2 diabetes mellitus	8.23e-05	0.000329	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.21e-05	0.000722	CbGpPWpGaD
Paricalcitol—Pruritus—Losartan—type 2 diabetes mellitus	8.21e-05	0.000329	CcSEcCtD
Paricalcitol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000328	CcSEcCtD
Paricalcitol—Headache—Metformin—type 2 diabetes mellitus	8.18e-05	0.000328	CcSEcCtD
Paricalcitol—Dizziness—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.000326	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000326	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—type 2 diabetes mellitus	8.09e-05	0.000711	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.01e-05	0.000704	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ACACA—type 2 diabetes mellitus	7.96e-05	0.0007	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.96e-05	0.0007	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—STAR—type 2 diabetes mellitus	7.96e-05	0.0007	CbGpPWpGaD
Paricalcitol—Diarrhoea—Losartan—type 2 diabetes mellitus	7.94e-05	0.000318	CcSEcCtD
Paricalcitol—Urticaria—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000316	CcSEcCtD
Paricalcitol—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000315	CcSEcCtD
Paricalcitol—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000315	CcSEcCtD
Paricalcitol—Vomiting—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000314	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—HK1—type 2 diabetes mellitus	7.81e-05	0.000687	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.8e-05	0.000686	CbGpPWpGaD
Paricalcitol—Rash—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000311	CcSEcCtD
Paricalcitol—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000311	CcSEcCtD
Paricalcitol—Nausea—Metformin—type 2 diabetes mellitus	7.76e-05	0.000311	CcSEcCtD
Paricalcitol—Headache—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000309	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	7.71e-05	0.000678	CbGpPWpGaD
Paricalcitol—Dizziness—Losartan—type 2 diabetes mellitus	7.67e-05	0.000307	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.63e-05	0.000671	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CBS—type 2 diabetes mellitus	7.63e-05	0.000671	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPA—type 2 diabetes mellitus	7.54e-05	0.000663	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.54e-05	0.000663	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.54e-05	0.000663	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GCKR—type 2 diabetes mellitus	7.54e-05	0.000663	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	7.41e-05	0.000652	CbGpPWpGaD
Paricalcitol—Vomiting—Losartan—type 2 diabetes mellitus	7.38e-05	0.000295	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—COX2—type 2 diabetes mellitus	7.34e-05	0.000646	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.34e-05	0.000646	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000293	CcSEcCtD
Paricalcitol—Nausea—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000293	CcSEcCtD
Paricalcitol—Rash—Losartan—type 2 diabetes mellitus	7.31e-05	0.000293	CcSEcCtD
Paricalcitol—Dermatitis—Losartan—type 2 diabetes mellitus	7.31e-05	0.000293	CcSEcCtD
Paricalcitol—Headache—Losartan—type 2 diabetes mellitus	7.27e-05	0.000291	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.25e-05	0.000638	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALDOB—type 2 diabetes mellitus	7.23e-05	0.000636	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	7.23e-05	0.000636	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.21e-05	0.000634	CbGpPWpGaD
Paricalcitol—Asthenia—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000286	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—UCP3—type 2 diabetes mellitus	7.09e-05	0.000623	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.09e-05	0.000623	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—UCP2—type 2 diabetes mellitus	7.09e-05	0.000623	CbGpPWpGaD
Paricalcitol—Pruritus—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000282	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.02e-05	0.000618	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	7.02e-05	0.000617	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	6.94e-05	0.00061	CbGpPWpGaD
Paricalcitol—Nausea—Losartan—type 2 diabetes mellitus	6.89e-05	0.000276	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.88e-05	0.000605	CbGpPWpGaD
Paricalcitol—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000272	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.8e-05	0.000598	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GLP1R—type 2 diabetes mellitus	6.72e-05	0.000591	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PCK1—type 2 diabetes mellitus	6.67e-05	0.000586	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HNF4A—type 2 diabetes mellitus	6.63e-05	0.000583	CbGpPWpGaD
Paricalcitol—Dizziness—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000263	CcSEcCtD
Paricalcitol—Vomiting—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000253	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.28e-05	0.000552	CbGpPWpGaD
Paricalcitol—Rash—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000251	CcSEcCtD
Paricalcitol—Dermatitis—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000251	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—HK1—type 2 diabetes mellitus	6.24e-05	0.000549	CbGpPWpGaD
Paricalcitol—Headache—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000249	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CPT1A—type 2 diabetes mellitus	6.15e-05	0.000541	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTR—type 2 diabetes mellitus	6.15e-05	0.000541	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.03e-05	0.00053	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GCKR—type 2 diabetes mellitus	6.03e-05	0.00053	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NAMPT—type 2 diabetes mellitus	6.03e-05	0.00053	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPA—type 2 diabetes mellitus	6.03e-05	0.00053	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.03e-05	0.00053	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.99e-05	0.000527	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HBA1—type 2 diabetes mellitus	5.99e-05	0.000527	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GCK—type 2 diabetes mellitus	5.99e-05	0.000527	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LIPC—type 2 diabetes mellitus	5.99e-05	0.000527	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	5.98e-05	0.000525	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.95e-05	0.000524	CbGpPWpGaD
Paricalcitol—Nausea—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000237	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.85e-05	0.000514	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PSMD6—type 2 diabetes mellitus	5.79e-05	0.000509	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DNMT1—type 2 diabetes mellitus	5.79e-05	0.000509	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CETP—type 2 diabetes mellitus	5.78e-05	0.000508	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.78e-05	0.000508	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CTGF—type 2 diabetes mellitus	5.68e-05	0.0005	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.39e-05	0.000474	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	5.38e-05	0.000473	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PSMD6—type 2 diabetes mellitus	5.37e-05	0.000473	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SREBF1—type 2 diabetes mellitus	5.37e-05	0.000473	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SNAP25—type 2 diabetes mellitus	5.37e-05	0.000473	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.37e-05	0.000473	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CTGF—type 2 diabetes mellitus	5.27e-05	0.000464	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMGCR—type 2 diabetes mellitus	5.23e-05	0.00046	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.16e-05	0.000453	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.12e-05	0.00045	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.02e-05	0.000441	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NOTCH2—type 2 diabetes mellitus	4.92e-05	0.000433	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.91e-05	0.000432	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.91e-05	0.000432	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTR—type 2 diabetes mellitus	4.91e-05	0.000432	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.86e-05	0.000427	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.86e-05	0.000427	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.82e-05	0.000424	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LIPC—type 2 diabetes mellitus	4.79e-05	0.000421	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HBA1—type 2 diabetes mellitus	4.79e-05	0.000421	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GCK—type 2 diabetes mellitus	4.79e-05	0.000421	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.76e-05	0.000419	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.74e-05	0.000417	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.72e-05	0.000415	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.67e-05	0.000411	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.67e-05	0.00041	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GCG—type 2 diabetes mellitus	4.66e-05	0.00041	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.66e-05	0.00041	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CETP—type 2 diabetes mellitus	4.62e-05	0.000406	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AR—type 2 diabetes mellitus	4.59e-05	0.000404	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.52e-05	0.000397	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.46e-05	0.000392	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.3e-05	0.000378	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.3e-05	0.000378	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.3e-05	0.000378	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CDKN2B—type 2 diabetes mellitus	4.23e-05	0.000372	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CTGF—type 2 diabetes mellitus	4.22e-05	0.000371	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SIRT1—type 2 diabetes mellitus	4.19e-05	0.000368	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.18e-05	0.000367	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.09e-05	0.00036	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GNB3—type 2 diabetes mellitus	4.02e-05	0.000353	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.02e-05	0.000353	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMOX1—type 2 diabetes mellitus	4e-05	0.000351	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAT—type 2 diabetes mellitus	3.94e-05	0.000347	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.93e-05	0.000345	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.89e-05	0.000342	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.89e-05	0.000342	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOB—type 2 diabetes mellitus	3.83e-05	0.000337	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP3A4—type 2 diabetes mellitus	3.79e-05	0.000333	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.73e-05	0.000328	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GCG—type 2 diabetes mellitus	3.72e-05	0.000328	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM1—type 2 diabetes mellitus	3.72e-05	0.000328	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.72e-05	0.000328	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR3C1—type 2 diabetes mellitus	3.71e-05	0.000327	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.7e-05	0.000325	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.69e-05	0.000324	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.68e-05	0.000323	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPL—type 2 diabetes mellitus	3.66e-05	0.000321	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.64e-05	0.00032	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ADCY5—type 2 diabetes mellitus	3.58e-05	0.000315	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GPX1—type 2 diabetes mellitus	3.57e-05	0.000314	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARA—type 2 diabetes mellitus	3.48e-05	0.000306	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CD36—type 2 diabetes mellitus	3.47e-05	0.000305	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.43e-05	0.000302	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—type 2 diabetes mellitus	3.29e-05	0.000289	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARA—type 2 diabetes mellitus	3.23e-05	0.000284	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GNB3—type 2 diabetes mellitus	3.21e-05	0.000282	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.21e-05	0.000282	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-05	0.000281	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAT—type 2 diabetes mellitus	3.15e-05	0.000277	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AGT—type 2 diabetes mellitus	3.13e-05	0.000275	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-05	0.00027	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOE—type 2 diabetes mellitus	3.06e-05	0.000269	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOB—type 2 diabetes mellitus	3.06e-05	0.000269	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA1—type 2 diabetes mellitus	3.03e-05	0.000266	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.98e-05	0.000262	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPL—type 2 diabetes mellitus	2.92e-05	0.000257	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARG—type 2 diabetes mellitus	2.88e-05	0.000253	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.86e-05	0.000252	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GPX1—type 2 diabetes mellitus	2.85e-05	0.000251	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.83e-05	0.000249	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.79e-05	0.000245	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CD36—type 2 diabetes mellitus	2.78e-05	0.000244	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.74e-05	0.000241	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARG—type 2 diabetes mellitus	2.67e-05	0.000235	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.63e-05	0.000231	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—INS—type 2 diabetes mellitus	2.62e-05	0.00023	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.59e-05	0.000228	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARA—type 2 diabetes mellitus	2.58e-05	0.000227	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AGT—type 2 diabetes mellitus	2.5e-05	0.00022	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-05	0.000216	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOE—type 2 diabetes mellitus	2.45e-05	0.000215	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA1—type 2 diabetes mellitus	2.42e-05	0.000213	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—type 2 diabetes mellitus	2.4e-05	0.000211	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-05	0.000202	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-05	0.000202	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.16e-05	0.00019	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARG—type 2 diabetes mellitus	2.13e-05	0.000188	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-05	0.000185	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—INS—type 2 diabetes mellitus	2.09e-05	0.000184	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—type 2 diabetes mellitus	1.92e-05	0.000169	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.88e-05	0.000166	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.88e-05	0.000166	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-05	0.000161	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-05	0.000161	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.79e-05	0.000157	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.79e-05	0.000157	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.7e-05	0.00015	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-05	0.000148	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.57e-05	0.000138	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.57e-05	0.000138	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.52e-05	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.52e-05	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.52e-05	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.52e-05	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.52e-05	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.47e-05	0.000129	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.39e-05	0.000122	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.39e-05	0.000122	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.35e-05	0.000119	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.29e-05	0.000114	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.29e-05	0.000114	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.29e-05	0.000114	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.24e-05	0.000109	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.24e-05	0.000109	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.19e-05	0.000105	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.19e-05	0.000105	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.17e-05	0.000103	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.15e-05	0.000101	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.15e-05	0.000101	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.15e-05	0.000101	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—type 2 diabetes mellitus	1.14e-05	0.0001	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.08e-05	9.52e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-05	9.28e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.01e-05	8.91e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.79e-06	8.61e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.79e-06	8.61e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.79e-06	8.61e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.79e-06	8.61e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.38e-06	8.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.72e-06	7.67e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—type 2 diabetes mellitus	8.44e-06	7.42e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.14e-06	7.16e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.98e-06	7.02e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.98e-06	7.02e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.82e-06	6.88e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.77e-06	6.84e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.77e-06	6.84e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.77e-06	6.84e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.73e-06	6.79e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.59e-06	6.67e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.5e-06	6.6e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.97e-06	6.13e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.97e-06	6.13e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.97e-06	6.13e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.84e-06	6.02e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.78e-06	5.96e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.64e-06	5.84e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.38e-06	5.61e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.31e-06	5.55e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.31e-06	5.55e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.05e-06	5.32e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.05e-06	5.32e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.21e-06	4.58e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.21e-06	4.58e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.19e-06	4.56e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.12e-06	4.5e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.97e-06	4.37e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.83e-06	4.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.74e-06	4.17e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.64e-06	4.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.63e-06	4.07e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.51e-06	3.96e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.45e-06	3.91e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.27e-06	3.76e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.19e-06	3.69e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.06e-06	3.57e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.99e-06	3.51e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.98e-06	3.5e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.93e-06	3.46e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.46e-06	3.05e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.4e-06	2.99e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.11e-06	2.74e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.98e-06	2.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.98e-06	2.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.73e-06	2.4e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-06	1.2e-05	CbGpPWpGaD
